Literature DB >> 9510204

Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma.

E M Hessel1, W W Cruikshank, I Van Ark, J J De Bie, B Van Esch, G Hofman, F P Nijkamp, D M Center, A J Van Oosterhout.   

Abstract

Experiments were designed to investigate the role of IL-16 in a mouse model of allergic asthma. OVA-sensitized mice were repeatedly exposed to OVA or saline aerosols. Bronchoalveolar lavage fluid (BALF) was collected after the last aerosol, and the presence of IL-16 was evaluated using a migration assay with human lymphocytes. Migration of lymphocytes was significantly increased in the presence of cell-free BALF from OVA-challenged mice compared with BALF from saline-challenged controls. This response was significantly inhibited after addition of antibodies to IL-16, demonstrating the presence of IL-16 in BALF of OVA-challenged animals. Immunohistochemistry was performed and revealed IL-16 immunoreactivity particularly in airway epithelial cells but also in cellular infiltrates in OVA-challenged mice. IL-16 immunoreactivity was absent in nonsensitized animals; however, some reactivity was detected in epithelial cells of sensitized but saline-challenged mice, suggesting that sensitization induced IL-16 expression in airway epithelium. Treatment of mice with antibodies to IL-16 during the challenge period significantly suppressed up-regulation of OVA-specific IgE in OVA-challenged animals. Furthermore, antibodies to IL-16 significantly inhibited the development of airway hyper-responsiveness after repeated OVA inhalations, whereas the number of eosinophils in bronchoalveolar lavage or airway tissue was not affected. In conclusion, IL-16 immunoreactivity is present in the airways after sensitization. After repeated OVA inhalation, IL-16 immunoreactivity is markedly increased and IL-16 is detectable in BALF. Furthermore, IL-16 plays an important role in airway hyper-responsiveness and up-regulation of IgE but is not important for eosinophil accumulation in a mouse model of allergic asthma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510204

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes.

Authors:  M Laan; I Qvarfordt; G C Riise; B A Andersson; S Larsson; A Lindén
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Dendritic cell responses to surface properties of clinical titanium surfaces.

Authors:  Peng Meng Kou; Zvi Schwartz; Barbara D Boyan; Julia E Babensee
Journal:  Acta Biomater       Date:  2010-10-25       Impact factor: 8.947

4.  Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes.

Authors:  N L Mathy; W Scheuer; M Lanzendörfer; K Honold; D Ambrosius; S Norley; R Kurth
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

5.  Interleukin-16 aggravates ovalbumin-induced allergic inflammation by enhancing Th2 and Th17 cytokine production in a mouse model.

Authors:  Chunxia Li; Jun Dai; Guanjun Dong; Qun Ma; Zhihua Li; Hui Zhang; Fenglian Yan; Junfeng Zhang; Bo Wang; Hui Shi; Yuzhen Zhu; Xiaoying Yao; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

6.  Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice.

Authors:  R B Muijsers; I van Ark; G Folkerts; A S Koster; A J van Oosterhout; D S Postma; F P Nijkamp
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

7.  Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells.

Authors:  Souad El Bassam; Stéphane Pinsonneault; Hardy Kornfeld; Fucheng Ren; José Menezes; Sophie Laberge
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

8.  Transient elevation of interleukin-16 levels at the initial stage of meningitis in children.

Authors:  T Suzuki; A Ishiguro; T Shimbo
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

9.  GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes.

Authors:  N Bannert; A Avots; M Baier; E Serfling; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.

Authors:  Shunsuke Tamaki; Toshiaki Mano; Yasushi Sakata; Tomohito Ohtani; Yasuharu Takeda; Daisuke Kamimura; Yosuke Omori; Yasumasa Tsukamoto; Yukitoshi Ikeya; Mari Kawai; Atsushi Kumanogoh; Keisuke Hagihara; Ryohei Ishii; Mitsuru Higashimori; Makoto Kaneko; Hidetoshi Hasuwa; Takeshi Miwa; Kazuhiro Yamamoto; Issei Komuro
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.